Krystal Biotech Inc. (KRYS)
NASDAQ: KRYS
· Real-Time Price · USD
150.42
0.09 (0.06%)
At close: Aug 15, 2025, 3:59 PM
147.27
-2.09%
After-hours: Aug 15, 2025, 07:11 PM EDT
Krystal Biotech Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 359.2M | 333.45M | 290.51M | 241.52M | 166.23M | 95.95M | 50.7M | 8.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 16.66M | 24.66M | 22.05M | 21.48M | 15.02M | 8.22M | 5.8M | 2.51M | 3.26M | 3.04M | 4.05M | 3.75M | 3.56M | 3.25M | 2.77M | 1.98M | 1.2M | 536K |
Gross Profit | 333.84M | 308.79M | 268.47M | 220.04M | 151.22M | 87.73M | 44.9M | 6.04M | -3.26M | -3.04M | -4.05M | -3.75M | -3.56M | -3.25M | -2.77M | -1.98M | -1.2M | -536K |
Operating Income | 139.3M | 121.06M | 78.19M | 39.95M | -8.47M | -67.59M | -109.73M | -147.63M | -153.09M | -143.8M | -145.2M | -132.3M | -116.5M | -104.14M | -68.27M | -56.82M | -50.85M | -41.41M |
Interest Income | 7.23M | 14.71M | 22.33M | 22.61M | 29.35M | 26.71M | 22.62M | 17.82M | 12.68M | 8.49M | 5.22M | 2.57M | 1.03M | 420K | 196K | 163K | 170K | 261K |
Pretax Income | 168.75M | 138.02M | 95.36M | 57.4M | 108.38M | 59.13M | 12.9M | -29.81M | -140.41M | -135.31M | -139.97M | -129.73M | -115.47M | -103.72M | -69.57M | -58.15M | -52.17M | -42.64M |
Net Income | 146.72M | 123.96M | 89.16M | 52.37M | 105.94M | 57.16M | 10.93M | -29.81M | -140.41M | -135.31M | -139.97M | -129.73M | -115.47M | -103.72M | -69.57M | -58.15M | -52.17M | -42.64M |
Selling & General & Admin | 127.88M | 118.36M | 111.7M | 103.67M | 98.65M | 98.92M | 96.89M | 97.67M | 93.9M | 85.86M | 77.74M | 66.57M | 56.21M | 48.15M | 40.39M | 32.27M | 27.28M | 20.8M |
Research & Development | 55.7M | 56.87M | 53.57M | 51.42M | 48.54M | 45.1M | 46.43M | 45.8M | 46.69M | 45.44M | 42.46M | 40.73M | 35.29M | 31M | 27.88M | 24.55M | 23.57M | 20.61M |
Other Expenses | 19.66M | 12.5M | 12.5M | 12.5M | 223K | 223K | 12.72M | 37.72M | 37.5M | 37.5M | 50M | 25M | 25M | 25M | n/a | n/a | n/a | n/a |
Operating Expenses | 203.25M | 187.74M | 177.77M | 167.59M | 147.41M | 144.24M | 156.05M | 156.19M | 153.09M | 143.8M | 120.2M | 107.3M | 91.5M | 79.14M | 68.27M | 56.82M | 50.85M | 41.41M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 257K | 257K | 257K | 257K | 1.49M | 1.49M | 1.49M | 1.49M |
Selling & Marketing Expenses | n/a | n/a | n/a | -50.38M | -50.38M | -50.38M | -50.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 163.17M | 212.39M | 199.82M | 189.06M | 162.21M | 151.04M | 160.43M | 156.19M | 153.09M | 143.8M | 120.2M | 107.3M | 91.5M | 79.14M | 68.27M | 56.82M | 50.85M | 41.41M |
Income Tax Expense | 5.14M | 14.06M | 11.08M | 9.91M | 7.33M | 6.85M | 1.97M | n/a | n/a | n/a | n/a | 71K | 134K | 165K | 198K | 127K | 64K | 33K |
Shares Outstanding (Basic) | 28.91M | 28.82M | 28.75M | 28.72M | 28.6M | 28.3M | 28.17M | 28.04M | 26.66M | 25.71M | 25.68M | 25.62M | 25.55M | 25.11M | 22.95M | 22.21M | 22.2M | 21.25M |
Shares Outstanding (Diluted) | 29.75M | 29.87M | 29.88M | 29.9M | 29.64M | 29.29M | 28.82M | 28.89M | 26.66M | 25.71M | 25.68M | 25.62M | 25.55M | 25.11M | 23.11M | 22.21M | 22.2M | 21.25M |
EPS (Basic) | 5.10 | 4.31 | 3.10 | 1.83 | 3.76 | 1.97 | 0.18 | -1.38 | -5.43 | -5.28 | -5.51 | -5.21 | -4.74 | -4.38 | -3.13 | -2.71 | -2.5 | -2.13 |
EPS (Diluted) | 4.92 | 4.16 | 2.99 | 1.77 | 3.65 | 1.87 | 0.08 | -1.47 | -5.43 | -5.28 | -5.51 | -5.2 | -4.73 | -4.37 | -3.12 | -2.71 | -2.5 | -2.13 |
EBITDA | 151.31M | 130.03M | 94.76M | 63.99M | 6.74M | -49.34M | -86.89M | -130.02M | -134.5M | -124.23M | -113.42M | -103.48M | -87.81M | -75.73M | -65.88M | -54.75M | -49.16M | -39.9M |
EBIT | 154.1M | 123.37M | 93.01M | 62.29M | 6.53M | -47.57M | -89.71M | -132.42M | -136.27M | -126.33M | -115.23M | -104.99M | -90.72M | -78.98M | -68.08M | -56.69M | -50.71M | -41.18M |
Depreciation & Amortization | 4.75M | 6.74M | 6.71M | 6.63M | 6.3M | 5.52M | 5.22M | 4.8M | 4.58M | 4.35M | 4.05M | 3.75M | 3.56M | 3.25M | 2.77M | 2.47M | 2.17M | 2.05M |